MedTrace Logo

Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease

NCT05604183 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-11-03

No results posted yet for this study

Summary

Two devices will be tested in this research:

1. Mantis Photonics' hyperspectral camera for non-invasive retinal examination (i.e., a hardware medical device under investigation).
2. Blekinge CoGNIT cognitive ability test (i.e., an assessment).

Conditions

Interventions

PROCEDURE

non-invasive hyperspectral retinoscopy

The Principal Investigator or a trained medical nurse (under the supervision of the principal investigator) will take an image of the retina of the patient with the Mantis Photonics hyperspectral retinoscopy camera.

PROCEDURE

blood sample

The Principle Investigator or a trained medical nurse (under the supervision of the Principal Investigator) will draw a small blood sample according to the standard medical procedures for drawing blood samples.

DIAGNOSTIC_TEST

Test of cognitive ability on tablet computer with CoGNIT software

The Principle Investigator or a trained medical nurse (under the supervision of the Principal Investigator) will give the patient to perform the digital cognitive test on a commercial tablet computer. The Principal Investigator or the medical nurse will be available for the patient to ask questions while the test is ongoing.

Sponsors & Collaborators

  • Blekinge Institute of Technology

    collaborator OTHER

  • Blekinge County Council Hospital

    collaborator OTHER

  • Mantis Photonics AB

    lead INDUSTRY

Principal Investigators

  • Anders Behrens, MD, PhD · Blekinge Tekniska Högskola

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2023-12-29
Completion
2023-12-29

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05604183 on ClinicalTrials.gov